Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

randomized-withdrawal study design

David R. Coghill (Lead / Corresponding author), Tobias Banaschewski, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Colleen S. Anderson, Richard Civil, Matthew Dauphin, Nicholas Higgins, Andrew Lyne, Maria Gasior, Liza A. Squires

    Research output: Contribution to journalArticle

    25 Citations (Scopus)
    125 Downloads (Pure)

    Abstract

    In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.
    Original languageEnglish
    Pages (from-to)647
    Number of pages657
    JournalJournal of the American Academy of Child & Adolescent Psychiatry
    Volume53
    Issue number6
    Early online date3 Mar 2014
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Attention Deficit Disorder with Hyperactivity
    Maintenance
    Lisdexamfetamine Dimesylate

    Cite this

    Coghill, David R. ; Banaschewski, Tobias ; Lecendreux, Michel ; Johnson, Mats ; Zuddas, Alessandro ; Anderson, Colleen S. ; Civil, Richard ; Dauphin, Matthew ; Higgins, Nicholas ; Lyne, Andrew ; Gasior, Maria ; Squires, Liza A. / Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder : randomized-withdrawal study design. In: Journal of the American Academy of Child & Adolescent Psychiatry. 2014 ; Vol. 53, No. 6. pp. 647.
    @article{6a0907635b484c1f924014c37584e350,
    title = "Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design",
    abstract = "In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.",
    author = "Coghill, {David R.} and Tobias Banaschewski and Michel Lecendreux and Mats Johnson and Alessandro Zuddas and Anderson, {Colleen S.} and Richard Civil and Matthew Dauphin and Nicholas Higgins and Andrew Lyne and Maria Gasior and Squires, {Liza A.}",
    note = "Copyright {\circledC} 2014 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.",
    year = "2014",
    doi = "10.1016/j.jaac.2014.01.017",
    language = "English",
    volume = "53",
    pages = "647",
    journal = "Journal of the American Academy of Child & Adolescent Psychiatry",
    issn = "0890-8567",
    publisher = "Elsevier",
    number = "6",

    }

    Coghill, DR, Banaschewski, T, Lecendreux, M, Johnson, M, Zuddas, A, Anderson, CS, Civil, R, Dauphin, M, Higgins, N, Lyne, A, Gasior, M & Squires, LA 2014, 'Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design', Journal of the American Academy of Child & Adolescent Psychiatry, vol. 53, no. 6, pp. 647. https://doi.org/10.1016/j.jaac.2014.01.017

    Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder : randomized-withdrawal study design. / Coghill, David R. (Lead / Corresponding author); Banaschewski, Tobias; Lecendreux, Michel; Johnson, Mats; Zuddas, Alessandro; Anderson, Colleen S.; Civil, Richard; Dauphin, Matthew; Higgins, Nicholas; Lyne, Andrew; Gasior, Maria; Squires, Liza A.

    In: Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 53, No. 6, 2014, p. 647.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

    T2 - randomized-withdrawal study design

    AU - Coghill, David R.

    AU - Banaschewski, Tobias

    AU - Lecendreux, Michel

    AU - Johnson, Mats

    AU - Zuddas, Alessandro

    AU - Anderson, Colleen S.

    AU - Civil, Richard

    AU - Dauphin, Matthew

    AU - Higgins, Nicholas

    AU - Lyne, Andrew

    AU - Gasior, Maria

    AU - Squires, Liza A.

    N1 - Copyright © 2014 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

    PY - 2014

    Y1 - 2014

    N2 - In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.

    AB - In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.

    U2 - 10.1016/j.jaac.2014.01.017

    DO - 10.1016/j.jaac.2014.01.017

    M3 - Article

    VL - 53

    SP - 647

    JO - Journal of the American Academy of Child & Adolescent Psychiatry

    JF - Journal of the American Academy of Child & Adolescent Psychiatry

    SN - 0890-8567

    IS - 6

    ER -